A key public health challenge is to identify individuals at high risk for common diseases in order to enable pre-screening or preventive therapies. Unlike Mendelian diseases, the pathogenesis of common diseases, which are caused by the interactions between multiple genetic and environmental factors, has not been elucidated. Therefore, identifying the risk factors that contribute to the substantial burden of common diseases and how to effectively identify high-risk incident cases from the general population are core goals of precision health.
Recently, polygenic risk scores have been proven to be superior in identifying high-risk individuals using genomic variants; the nonlinear interactions between the variants and the other types of information (such as transcriptomics, proteomics, microbiomics, lifestyles, lab test results, etc.) are omitted. Multi-omics data have been adopted to decipher the disease biological risk factors based on human genome sequencing, metagenome sequencing, single-cell sequencing, etc. With the advances of high-throughput sequencing technologies, new computational algorithms and tailored analysis techniques promise to identify novel disease risk factors and ultimately lead to the development of clinically relevant biomarkers for disease prediction. The epidemiological factors interacting with these genetic factors also influence the disease onset age and severity. Large public health cohorts such as UK Biobank provide an opportunity to build a more comprehensive and multi-view picture of disease risk factors. These data pose a big practical challenge in developing computational algorithms for identifying individuals with a high risk for disease from the general population.
We welcome investigators to contribute Original Research as well as Review articles on both data analytics and computational methods to identify novel biological and epidemiological risk factors (the novel risk factors should be replicated in at least one independent cohort) and explore the individuals at high risk for disease. Potential topics include but are not limited to the following:
• Identifying multi-omics disease risk biomarkers
• Identifying key driver genes and their interaction network for common diseases
• Metagenomic risk factors associated with common human diseases
• Identifying novel genetic and epidemiological disease risk factors
• Integrating medical images, electronic clinical records, and genotype data for disease early diagnosis and prediction
• Novel statistical methods for computing polygenic risk scores
Please note that studies proposing novel biomarkers must include molecular validation.
A key public health challenge is to identify individuals at high risk for common diseases in order to enable pre-screening or preventive therapies. Unlike Mendelian diseases, the pathogenesis of common diseases, which are caused by the interactions between multiple genetic and environmental factors, has not been elucidated. Therefore, identifying the risk factors that contribute to the substantial burden of common diseases and how to effectively identify high-risk incident cases from the general population are core goals of precision health.
Recently, polygenic risk scores have been proven to be superior in identifying high-risk individuals using genomic variants; the nonlinear interactions between the variants and the other types of information (such as transcriptomics, proteomics, microbiomics, lifestyles, lab test results, etc.) are omitted. Multi-omics data have been adopted to decipher the disease biological risk factors based on human genome sequencing, metagenome sequencing, single-cell sequencing, etc. With the advances of high-throughput sequencing technologies, new computational algorithms and tailored analysis techniques promise to identify novel disease risk factors and ultimately lead to the development of clinically relevant biomarkers for disease prediction. The epidemiological factors interacting with these genetic factors also influence the disease onset age and severity. Large public health cohorts such as UK Biobank provide an opportunity to build a more comprehensive and multi-view picture of disease risk factors. These data pose a big practical challenge in developing computational algorithms for identifying individuals with a high risk for disease from the general population.
We welcome investigators to contribute Original Research as well as Review articles on both data analytics and computational methods to identify novel biological and epidemiological risk factors (the novel risk factors should be replicated in at least one independent cohort) and explore the individuals at high risk for disease. Potential topics include but are not limited to the following:
• Identifying multi-omics disease risk biomarkers
• Identifying key driver genes and their interaction network for common diseases
• Metagenomic risk factors associated with common human diseases
• Identifying novel genetic and epidemiological disease risk factors
• Integrating medical images, electronic clinical records, and genotype data for disease early diagnosis and prediction
• Novel statistical methods for computing polygenic risk scores
Please note that studies proposing novel biomarkers must include molecular validation.
